Structure-Based Design of Bioavailable Macrocycle Therapeutics

We are developing macrocycle therapeutics to address “undruggable” targets.  Our pipeline is focused in precision oncology.

Structure-Based Design of Bioavailable Macrocycle Therapeutics

We are developing macrocycle therapeutics to address “undruggable” targets.  Our pipeline is focused in precision oncology.

A new paradigm for macrocycle drug discovery

We are deploying a platform that combines structure-based rational drug design and advanced synthetic chemistry to develop first-in-class macrocycle therapeutics for challenging targets to address unmet clinical needs.

Circle Pharma Achieves Major Milestone with the Selection of a Clinical Development Candidate Directly Inhibiting Cyclins A and B

We are hiring !

And are looking forward to receiving your application.